Fitusiran, an investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia: Interim results from a phase 2 extension study in patients with hemophilia A or B with and without inhibitors - Pasi, K J; Lissitchkov, T; Georgiev, P (Res Pract Thromb Haemost, 2017)